SG2918 For Advanced Malignant Tumors

Clinical trial NCT06167486 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06167486
Sponsor: Hangzhou Sumgen Biotech Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2023-12-26
Primary completion: 2025-11-11
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.